To access this element change to forms mode OFF
Grant Award View - GA289084
Strategies and Treatments for Respiratory Infections and Viral...
GA ID:
GA289084
Agency:
Department of Health and Aged Care
Approval Date:
19-Nov-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Jan-2027
Value (AUD):
$1,993,166.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE)
Purpose:
Despite highly active treatments for people with early COVID-19 infection, therapies for people who have severe disease are much less effective. A global master platform study called STRIVE has commenced to study the most effective treatments and strategies in people who are hospitalised with severe respiratory illness. The first trial in this platform will study a novel antiviral drug for COVID-19. This application aims to support ten Australian sites to join this new international network.
GO ID:
GO Title:
MRFF Clinical Trials Activity Initiative - 2022 International Clinical Trial Collaborations Grant Opportunity
Internal Reference ID:
2022/MRF2023831
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA, WA, QLD
Postcode:
Multiple
Country:
AUSTRALIA